Progressive Care Inc (RXMD)

[Jimmy Quick]

Well we have had 2 PRs hit this month, and none of them have been about revenues, acquisitions, SEC filing, or CBD manufacturing partnership agreement. And we are up over 40%, I think we are showing some good signs here.

$RXMD Up 40% last 5 days Making Investing Easy so you can Sleep Easy
REAL COMPANY - OTCQB, 2 YEARS AUDITED FINANCIALS, Over 20 MILLION NET ANNUAL REVS and soon to be over 40 MILLION NET REVENUES – HUGE LONGTERM INVESTMENT POTENTIAL

What's happening for RXMD?

Seven things specifically come to mind.


1. December 2018 revenues will be reported in next week.
REVENUES ACHIEVED YTD


2. $18 Million Annual Revenue Purchase of Florida Base Pharmacy, as pretty much confirmed by the new Funding Facility Agreement - Terms were Great by the Way – Kudos Benchmark on the Assistance.

Everything is moving forward as planned. Working hard on it right now to get the deal closed.

Progressive Care Signs Letter of Intent to Purchase Florida Based Pharmacy with $18 million in Annual Revenue

MIAMI, FL -- November 28, 2018 -- InvestorsHub NewsWire -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that it has entered into a letter of intent to purchase a Florida based pharmacy with 2 operating locations.

On November 27, 2018, Progressive Care executed a letter of intent to purchase a Florida based pharmacy with locations in Davie and Orlando, Florida. The target pharmacy had just under $16 million in revenue in 2017 and is projected to have approximately $18 million for 2018. The agreement calls for a stratified payment structure for the total purchase price of $3,000,000. $2.3 million in cash spread over 2 years and $700,000 in stock valued at market price at closing or $0.07 whichever is lower. The signing is expected to take place no later than January 15, 2019 after the completion of a 45-day due diligence period.

"We have devoted our efforts to grow the company and expand its geographical coverage," said S. Parikh Mars, Chief Executive Officer of Progressive Care Inc. "This LOI is a significant step towards our development and presence in the industry. We are excited to add another pharmacy with its exceptional team to our family and platform."

3. Annual Shareholder Letter for 2019 Forecast and Goals

4. 3rd Year of Audited Financial Statements and Conference Call to Discuss Results.

5. CBD Manufacturer Partnership Agreement

Armen said they are currently working on the final agreements and some other related work. He is positive this project is moving forward as planned.

So we're going to put our name behind these products, which is a big deal. Again not all CBD is made alike. This is going to be our reputation on the line with the CBD brand and we have two manufacturers that we're working on NDA's with to explore those partnerships. So very exciting times. Look out for more updates in January after the Farm bill but we're not waiting for January. We're trying to get things in place so that once the Farmville passes, we can start moving forward on production.

6. Announcement of SEC Registration Completion

Progressive Care will audit the new Orlando pharmacy’s financials once the acquisition is completed. They will file SEC together. He’s still expecting sometime late March, early April.

7. Tele-Pharmacy Licensing Deals

We're are going to be a technology company too. If you look five years from now, CVS, Walgreens, Walmart will be using the solutions we developed and we pioneered and they're going to have to look at us for what we just like the Xerox years ago, had developed all of this tech that were then used by other people.

I don't want to be the Xerox, we're going to own that tech. We're going to be the one you have to come to if you want to advance in the technology sphere of patient management, of healthcare management, of telemedicine, of tele-pharmacy, of whatever. If you're helping a patient and healthcare happens at home, somewhere PharmCo and Progressive Care is going to be involved. So that's the future. That's what we're working toward and that's what all of our shareholders have to look forward to.

ALL OF THIS COULD LEAD TO A SIMILAR SITUATION AS BELOW IN THE FUTURE IN TERMS OF VALUATION – AGAIN HUGE LONGTERM INVESTEMENT POTENTIAL

LOOK AT AMAZONS BUY OF PILLPACK for around $1 Billion, and PillPack revenues were $100 million. RXMD has a ton of revenues. Over $20 million net revenues for FY 2018 and has acquired 2nd location.